Management of rare mutations in non-small cell lung cancer (NSCLC) – PART 3: HER2
Human epidermal growth factor receptor 2 (HER2) is a member of the ERBB receptor tyrosine kinase family. It is...
cancer treatment
Ovarian Cancer: The new normal- Standards of care before, during and after the pandemic – Part 1
COVID-19 is a severe acute respiratory syndrome that has blighted the world over the last year. The World Health...
Metastasis Prevention – A New Weapon in the Fight Against Cancer
Despite years of research, cancer metastasis always remains incurable and fatal. There are no approved drugs for the prevention...
A checkpoint inhibitor gains FDA approval in endometrial cancer
On April 22, 2021, the US Food and Drug Administration (FDA) granted Accelerated Approval to dostarlimab (Jemperli, GlaxoSmithKline) as...